Therefore, it is suggested downregulation of KAP activity by aberrant splicing or overexpression of microRNA facilitates GBM cell oncogenicity at least in part by promoting migration in a CDC2-dependent manner. The gene discussed is CDKN3; the disease is glioblastoma.